COVID-19 drug for outpatients tested
Scientists at Stanford Medicine are investigating whether a molecule called interferon-lambda can help people with mild cases of COVID-19 feel better and reduce their transmission of the disease-causing virus.
HIV vaccine proves effective in primates
Most vaccines direct the adaptive immune system to fight off infections with one arm tied behind its back. A new study in monkeys untied the other arm.
Twin registry gets new home at Stanford
Studies of identical versus fraternal twins reveal the relative contributions of heredity and the environment to numerous human traits. Now, Stanford has its own twin registry.
Valve helps emphysema patients breathe easier
Allen Eddy underwent a procedure to insert a device, the Zephyr valve, into the diseased portion of his upper left lung lobe. He had no idea it would help so much.
Stanford Health Care earns A for safety
The hospitals earned top grades in the latest patient-safety assessments by The Leapfrog Group, a national health care watchdog organization.
Roeland Nusse receives Gairdner award
The Stanford developmental biologist was honored for a lifetime of work on the Wnt signaling pathway, which plays an important role in normal development and in cancer.
Stanford Health Care resumes most procedures
With extensive testing showing very low COVID-19 infection rates and with many safety measures in place, Stanford Health Care providers are now performing almost all medical procedures, including surgeries, diagnostic imaging and routine screenings.
Brain abnormalities in PANS
MRI brain scans show subtle changes consistent with inflammation in a severe childhood disease in which the immune system is thought to attack the brain, Stanford researchers found.
Emergency approval of remdesivir for COVID-19
Stanford Medicine researchers who participated in two separate clinical trials are encouraged by data indicating that remdesivir can treat COVID-19.
New members of the National Academy of Sciences
Howard Chang of dermatology and of genetics, Richard Lewis of molecular and cellular physiology, and Peter Sarnow of microbiology and immunology were elected to the National Academy of Sciences.